Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: Vemurafenib (PLX4032)
Rajendar K. Mittapalli, Shruthi Vaidhyanathan, Ramola Sane, William F. Elmquist
Dive into the research topics of 'Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: Vemurafenib (PLX4032)'. Together they form a unique fingerprint.